Directorate change - THC Dartford Issuer Plc

Summary by AI BETAClose X

The Hospital Company (Dartford) Issuer plc announced directorate changes effective November 30, 2025, with Daniel Geoffrey North stepping down as Nominated Director on behalf of Semperian PPP Investment Partners No.2 Limited. Louis Javier Falero has been appointed as the new Nominated Director for Semperian PPP Investment Partners No.2 Limited, and Gary Brown will serve as alternate Director to Mr. Falero. These changes are in accordance with Listing Rule 9.6.11R.

Disclaimer*

Hospital Co (Dartford) Issuer PLC
12 December 2025
 

The Hospital Company (Dartford) Issuer plc

Directorate Change

 

In accordance with Listing Rule 9.6.11R, The Hospital Company (Dartford) Issuer plc confirms the following directorate changes to the Board of Directors of The Hospital Company (Dartford) Issuer plc, effective 30 November 2025:

 

·       Daniel Geoffrey North stepped down from his role as Nominated Director (on behalf of Semperian PPP Investment Partners No.2 Limited).

·       Louis Javier Falero has been appointed to the role of Nominated Director (on behalf of Semperian PPP Investment Partners No.2 Limited).

·       Gary Brown will be appointed to the role of alternate Director to Javier Falero.

 

Enquiries:

 

Amanda Teggart

Email: amanda.teggart@semperian.co.uk

Phone: +442034051317
Mobile: +447697 317252

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings